Back to Market Feed

Product Information

WEGOVY 0.5 MG/0.5 ML PEN is a brand product labeled by Novo Nordisk, priced at $653.2446 per ML under NDC 00169450514. Its NADAC has been published 235 times since Sep 22, 2021.

FDA first approved this application on Jun 4, 2021.

WEGOVY 0.5 MG/0.5 ML PEN

semaglutide
$653.2446per ML

Strength

.5 mg/.5mL

Manufacturer

Novo Nordisk

NDC

00169450514

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

SEMAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA215256

FDA Approved

6/4/2021

On Market Since

6/5/2021

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for WEGOVY 0.5 MG/0.5 ML PEN has been published 235 times since Sep 22, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$653.2446 per ML
All-time high$653.6520 (Apr 15, 2026)
All-time low$644.4288 (Feb 22, 2023)
52-week high$653.6520
52-week low$652.2154
Median price$650.4976
Average price$649.8372
Largest weekly change+0.6% (Sep 20, 2023)
Weeks tracked235
Tracking sinceSep 22, 2021

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

+0.2%

3Y

+1.0%

5Y

N/A

All

+0.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the semaglutide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1616
per EA
RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1625
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1945
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0873
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8981
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1370
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7416
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8142
per ML
BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
per ML
TRULICITY 4.5 MG/0.5 ML PEN
Brand
00002318280•Eli Lilly and Company
$487.3750
per ML

Frequently asked questions

What is the NADAC price of WEGOVY 0.5 MG/0.5 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for WEGOVY 0.5 MG/0.5 ML PEN, manufactured by Novo Nordisk, is $653.2446 per ML (NDC 00169450514), effective Aug 19, 2026.

How has the price of WEGOVY 0.5 MG/0.5 ML PEN changed over time?

Over the history we have for it, the NADAC for WEGOVY 0.5 MG/0.5 ML PEN has held within roughly two percent of its current level. It has been tracked across 235 weekly CMS publications since Sep 22, 2021.

What are the highest and lowest recorded NADAC prices for WEGOVY 0.5 MG/0.5 ML PEN?

Since Sep 22, 2021, the NADAC for WEGOVY 0.5 MG/0.5 ML PEN has ranged from a low of $644.4288 (Feb 22, 2023) to a high of $653.6520 (Apr 15, 2026), with a median of $650.4976 per ML.

Are there cheaper alternatives to WEGOVY 0.5 MG/0.5 ML PEN?

No other NADAC-published product currently shares the active ingredient and strength of WEGOVY 0.5 MG/0.5 ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures WEGOVY 0.5 MG/0.5 ML PEN?

WEGOVY 0.5 MG/0.5 ML PEN (NDC 00169450514) is labeled by Novo Nordisk, and CMS classifies it as a brand product.